Butler, T. M., Johnson-Camacho, K., Peto, M., Wang, N. J., Macey, T. A., Korkola, J. E., . . . Spellman, P. T. (2015). Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease. PLoS ONE, 10(8), 1. https://doi.org/10.1371/journal.pone.0136407
Chicago Style (17th ed.) CitationButler, Timothy M., et al. "Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease." PLoS ONE 10, no. 8 (2015): 1. https://doi.org/10.1371/journal.pone.0136407.
MLA (9th ed.) CitationButler, Timothy M., et al. "Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease." PLoS ONE, vol. 10, no. 8, 2015, p. 1, https://doi.org/10.1371/journal.pone.0136407.